Tag: Prescription Drugs
ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients
Patients with advanced disease lived longer when they received this targeted treatment
ASCO: Extension of Aromatase Inhibitor Tx Benefits Breast CA
Extension of aromatase inhibitor treatment to 10 years linked to higher rates of disease-free survival
Serious Bleeding Risks Linked to OTC Antacids Containing Aspirin
Alka Seltzer, Bromo Seltzer among over-the-counter products vulnerable patients should avoid, FDA says
Spironolactone No Benefit for Knee OA in Older Adults
No improvements seen in symptoms, physical function, or health-related quality of life
Contraindication to Antiplatelet Rx for ~18 Percent With PCI
Six percent of these patients receive antiplatelets; no increased mortality with contraindicated med use
Meds to Treat Opioid Addiction Significantly Underused
In 2013, just 17 percent were given medications like naltrexone after hospital discharge
Many Still on Opioids Six Months After Total Joint Arthroplasty
Study findings highlight growing epidemic
Vigilance Urged for Heparin-Induced Thrombocytopenia
Heparin should be terminated on suspicion of HIT; alternative anticoagulants recommended
Prophylactic Antibiotics Cut Risk of Anti-EGFR Skin Rash
Systematic review shows reduction in risk of developing a skin rash with prophylactic antibiotics
![A decision tool (dual antiplatelet therapy [DAPT] score) improves risk prediction for continued DAPT beyond assessment of myocardial infarction history](https://www.ehealth-news.com/wp-content/uploads/2016/06/heart0331.jpeg "DAPT Score Improves Risk Prediction of Continued DAPT")
DAPT Score Improves Risk Prediction of Continued DAPT
Score improves prediction of benefit and harm for continued DAPT therapy beyond MI history alone
